Camelpox Virus in Western Kazakhstan: Isolation and Phylogenetic Analysis of a New Strain

Viruses, 2025

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.3390/v17091229
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

This study continues earlier work aimed at identifying potential natural reservoirs of camelpox virus (CMLV) during interepizootic periods. In 2023-2024, field expeditions in western Kazakhstan led to the collection and analysis of biological samples from camels, rodents and hematophagous insects. Despite the absence of clinical symptoms, PCR-positive results were obtained from camel blood samples. These samples underwent molecular genetic analysis, including viral DNA detection and whole-genome sequenc-ing. Using next-generation sequencing, the complete genome of the Camelpox vi-rus/Beineu/2023 isolate (202.273 bp) was obtained and deposited in the NCBI database (accession number PV920573.1). The isolate showed >98% genetic similarity to the previ-ously described Kazakhstan strain M-96, indicating long-term local circulation of a genet-ically stable variant. Phylogenetic analysis confirmed the isolate’s evolutionary conserva-tism and close relationship with other CMLV strains. The findings suggest that camels serve as a natural reservoir, enabling viral persistence and potential reactivation under stress-related conditions. The observed geographic clustering underscores the need for re-gion-specific molecular surveillance to ensure timely detection of new variants and pre-vent cross-border spread.